UCB SA - Asset Resilience Ratio

Latest as of December 2025: 1.21%

UCB SA (UCB) has an Asset Resilience Ratio of 1.21% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

€219.00 Million

Cash + Short-term Investments

Total Assets

€18.16 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how UCB SA's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down UCB SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€219.00 Million	1.21%
Total Liquid Assets	€219.00 Million	1.21%

Asset Resilience Insights

Limited Liquidity: UCB SA maintains only 1.21% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

UCB SA Industry Peers by Asset Resilience Ratio

Compare UCB SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	25.67%
ACRO Biomedical Co., Ltd. TWO:6748	Biotechnology	60.44%
Shenzhen CAU Technology Co Ltd SHE:000004	Biotechnology	6.20%
Pacific Shuanglin Bio pharmacy Co Ltd SHE:000403	Biotechnology	6.88%
Nanhua Bio Medicine Co Ltd SHE:000504	Biotechnology	11.93%
Jiangsu Sihuan Bioengineering Co Ltd SHE:000518	Biotechnology	0.03%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%
Hualan Biological EngineeringInc SHE:002007	Biotechnology	14.68%

Annual Asset Resilience Ratio for UCB SA (2000–2025)

The table below shows the annual Asset Resilience Ratio data for UCB SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.21%	€219.00 Million	€18.16 Billion	+0.15pp
2024-12-31	1.06%	€184.00 Million	€17.35 Billion	+0.37pp
2023-12-31	0.70%	€108.00 Million	€15.54 Billion	-0.38pp
2022-12-31	1.07%	€170.00 Million	€15.87 Billion	+0.30pp
2021-12-31	0.77%	€110.00 Million	€14.21 Billion	-4.51pp
2020-12-31	5.29%	€704.00 Million	€13.32 Billion	-3.64pp
2019-12-31	8.93%	€989.00 Million	€11.08 Billion	+8.76pp
2018-12-31	0.16%	€17.00 Million	€10.51 Billion	+0.02pp
2017-12-31	0.14%	€14.00 Million	€9.92 Billion	-0.31pp
2016-12-31	0.45%	€46.00 Million	€10.21 Billion	+0.14pp
2015-12-31	0.31%	€34.00 Million	€10.96 Billion	+0.30pp
2014-12-31	0.01%	€1.00 Million	€10.15 Billion	0.00pp
2013-12-31	0.01%	€1.00 Million	€9.76 Billion	-0.08pp
2012-12-31	0.09%	€8.00 Million	€9.36 Billion	-0.33pp
2011-12-31	0.41%	€38.00 Million	€9.18 Billion	-0.27pp
2010-12-31	0.68%	€61.00 Million	€8.97 Billion	+0.10pp
2009-12-31	0.58%	€53.00 Million	€9.12 Billion	+0.55pp
2008-12-31	0.03%	€3.00 Million	€9.52 Billion	-0.97pp
2007-12-31	1.00%	€96.00 Million	€9.55 Billion	-6.45pp
2004-12-31	7.45%	€400.36 Million	€5.37 Billion	-4.17pp
2003-12-31	11.62%	€359.05 Million	€3.09 Billion	-4.44pp
2002-12-31	16.05%	€420.73 Million	€2.62 Billion	+2.83pp
2001-12-31	13.22%	€339.05 Million	€2.56 Billion	+1.63pp
2000-12-31	11.59%	€266.93 Million	€2.30 Billion	--

pp = percentage points

About UCB SA

BR:UCB Belgium Biotechnology

Market Cap

$57.57 Billion

€49.25 Billion EUR

Market Cap Rank

#448 Global

#2 in Belgium

Share Price

€258.70

Change (1 day)

-2.63%

52-Week Range

€140.20 - €285.40

All Time High

€285.40